EPAS1 and hepatocellular carcinoma: More recently, it has been reported that SerpinB3, a serine protease inhibitor produced by hepatocytes exposed to hypoxia selectively through HIF-2α transcriptional activity and found to be upregulated during CLD progression and HCC development [130,131], was able to exert a pro-fibrogenic action [132].